Simonetta Viviani
- Pathology and Forensic Medicine top 0.2%
- Lymphoma Diagnosis and Treatment 85
- Neurology top 1%
- CNS Lymphoma Diagnosis and Treatment 20
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research 31
- Oncology top 1%
- Viral-associated cancers and disorders 19
- Cancer Treatment and Pharmacology 7
-
- Lung Cancer Treatments and Mutations 35
-
- Reproductive Biology and Fertility 6
-
- Cutaneous lymphoproliferative disorders research 6
- Co-authors
- V. BonfanteGianni BonadonnaPinuccia ValagussaArmando SantoroLiliana DevizziG. RagniAlessandro M. GianniAnna Russo
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Simonetta Viviani
115 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 100
- Pathology and Forensic Medicine 3.2k
- Neurology 1.2k
- Genetics 755
- Oncology 1.9k
- Pulmonary and Respiratory Medicine 1.2k
Countries citing papers authored by Simonetta Viviani
This map shows the geographic impact of Simonetta Viviani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simonetta Viviani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simonetta Viviani more than expected).
Fields of papers citing papers by Simonetta Viviani
This network shows the impact of papers produced by Simonetta Viviani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simonetta Viviani. The network helps show where Simonetta Viviani may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Simonetta Viviani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2023 | 3 | |
| 3 | 2017 | 13 | |
| 4 | 2014 | 27 | |
| 5 | 2013 | 50 | |
| 6 | 2011 | 268 | |
| 7 | 2010 | 24 | |
| 8 | 2010 | 102 | |
| 9 | Early Interim 2-[ 18 F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Studybreakdown → | 2007 | 552 |
| 10 | 2006 | 32 | |
| 11 | 2001 | 14 | |
| 12 | 2000 | 12 | |
| 13 | 1996 | 125 | |
| 14 | 1994 | 36 | |
| 15 | 1994 | 66 | |
| 16 | 1994 | 6 | |
| 17 | 1993 | 16 | |
| 18 | 1991 | 63 | |
| 19 | 1990 | 12 | |
| 20 | 1987 | 23 |
About Simonetta Viviani
Simonetta Viviani is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology, having authored 119 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (85 papers), Lung Cancer Treatments and Mutations (35 papers), Chronic Lymphocytic Leukemia Research (31 papers), CNS Lymphoma Diagnosis and Treatment (20 papers), Viral-associated cancers and disorders (19 papers), Cancer Treatment and Pharmacology (7 papers), Reproductive Biology and Fertility (6 papers) and Cutaneous lymphoproliferative disorders research (6 papers). The work is most often cited by research in Pathology and Forensic Medicine (3.2k citations), Neurology (1.2k citations) and Genetics (755 citations). Simonetta Viviani has collaborated with scholars based in Italy, United States and France. Frequent co-authors include V. Bonfante, Gianni Bonadonna, Pinuccia Valagussa, Armando Santoro, Liliana Devizzi, G. Ragni, Alessandro M. Gianni, Anna Russo, O Bestetti and Andrea Gallamini. Their work appears in journals such as Blood, Journal of Clinical Oncology, Annals of Oncology, European Journal of Cancer and Hematological Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.